XTX Topco Ltd Makes New Investment in Oscar Health, Inc. (NYSE:OSCR)

Key Points

• XTX Topco Ltd invested approximately $613,000 in Oscar Health, acquiring 46,791 shares of the company in the first quarter.
• Several institutional investors have also adjusted their stakes in Oscar Health, with 75.70% of the stock now owned by institutional holders.
• Analysts have downgraded Oscar Health's stock, with multiple price targets being lowered, setting the current consensus target at $12.21.

XTX Topco Ltd acquired a new position in Oscar Health, Inc. (NYSE:OSCR - Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The fund acquired 46,791 shares of the company's stock, valued at approximately $613,000.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Larson Financial Group LLC lifted its holdings in Oscar Health by 83,733.3% during the 1st quarter. Larson Financial Group LLC now owns 2,515 shares of the company's stock worth $33,000 after buying an additional 2,512 shares during the last quarter. CWM LLC boosted its holdings in Oscar Health by 50.7% in the first quarter. CWM LLC now owns 3,204 shares of the company's stock worth $42,000 after purchasing an additional 1,078 shares during the period. Princeton Global Asset Management LLC bought a new stake in Oscar Health during the first quarter valued at $59,000. GAMMA Investing LLC boosted its holdings in shares of Oscar Health by 2,156.4% in the 1st quarter. GAMMA Investing LLC now owns 6,476 shares of the company's stock valued at $85,000 after buying an additional 6,189 shares during the period. Finally, Tower Research Capital LLC TRC lifted its holdings in Oscar Health by 171.4% in the fourth quarter. Tower Research Capital LLC TRC now owns 6,627 shares of the company's stock worth $89,000 after acquiring an additional 4,185 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company's stock.

Insider Transactions at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the stock in a transaction that occurred on Monday, May 12th. The stock was sold at an average price of $16.43, for a total transaction of $410,750.00. Following the transaction, the director owned 64,512 shares in the company, valued at approximately $1,059,932.16. This trade represents a 27.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 24.39% of the stock is owned by corporate insiders.

Oscar Health Trading Up 1.8%

NYSE:OSCR traded up $0.27 during trading hours on Friday, hitting $15.43. The stock had a trading volume of 16,205,542 shares, compared to its average volume of 13,211,853. The company has a market cap of $3.93 billion, a price-to-earnings ratio of -19.05 and a beta of 1.86. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.79. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.88 and a current ratio of 0.88. The business's 50 day moving average is $15.87 and its 200-day moving average is $14.86.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.90) by $0.01. The business had revenue of $2.86 billion for the quarter, compared to analyst estimates of $2.88 billion. Oscar Health had a negative return on equity of 13.75% and a negative net margin of 1.50%. Oscar Health's revenue for the quarter was up 29.0% compared to the same quarter last year. During the same quarter last year, the firm earned $0.20 EPS. Sell-side analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently commented on OSCR. UBS Group reaffirmed a "sell" rating and set a $11.00 target price (down from $15.00) on shares of Oscar Health in a report on Tuesday, July 15th. Wells Fargo & Company lowered Oscar Health from an "equal weight" rating to an "underweight" rating and dropped their target price for the stock from $16.00 to $10.00 in a research report on Friday, July 11th. Barclays cut their target price on Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a research note on Wednesday, July 23rd. Baird R W lowered shares of Oscar Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 25th. Finally, Robert W. Baird reiterated a "neutral" rating and issued a $14.00 price objective (down from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. Five equities research analysts have rated the stock with a sell rating and five have issued a hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $12.21.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.